Nothing Special   »   [go: up one dir, main page]
Skip to main content
Springer Nature Link
Log in

Breast MRI Screening: Benefits and Limitations

  • Screening and Imaging (HTC Le-Petross, Section Editor)
  • Published:
Current Breast Cancer Reports Aims and scope Submit manuscript

Abstract

Multiple studies have demonstrated screening mammography’s ability to decrease mortality in average risk women. It is also recognized that women at high risk for breast cancer who choose surveillance benefit from additional imaging strategies for cancer detection in addition to mammography alone. Contrast-enhanced breast MRI has become a standard and accepted tool in the screening evaluation of women with a high risk of breast cancer. However, despite recognition of MRI’s ability to detect breast cancer in the screening setting in a high-risk population, there are still questions surrounding the use of breast MRI in the screening environment. This chapter will provide an overview of breast screening MRI indications and current guidelines and will also review the evidence supporting the use of screening breast MRI.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Breast Cancer Statistics. WCRF International, London, UK. http://www.wcrf.org/int/cancer-facts-figures/data-specific-cancers/breast-cancer-statistics. Accessed 8 June 2016.

  2. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin. 2016;66(1):7–30.

    Article  PubMed  Google Scholar 

  3. Heywang-Kobrunner SH, Hacker A, Sedlacek S. Advantages and disadvantages of mammography screening. Breast Care (Basel). 2011;6(3):199–207.

    Article  Google Scholar 

  4. Warner E. Clinical practice. Breast-cancer screening. N Engl J Med. 2011;365(11):1025–32.

    Article  CAS  PubMed  Google Scholar 

  5. Saslow D, Boetes C, Burke W, Harms S, Leach MO, Lehman CD, et al. American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin. 2007;57(2):75–89.

    Article  PubMed  Google Scholar 

  6. Familial breast cancer: classification and care of people at risk of familial breast cancer and management of breast cancer and related risks in people with a family history of breast cancer. National Institute for Health and Clinical Excellence: Guidance. Cardiff (UK)2013.

  7. Mann RM, Kuhl CK, Kinkel K, Boetes C. Breast MRI: guidelines from the European Society of Breast Imaging. Eur Radiol. 2008;18(7):1307–18.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Mann RM, Balleyguier C, Baltzer PA, Bick U, Colin C, Cornford E, et al. Breast MRI: EUSOBI recommendations for women’s information. Eur Radiol. 2015;25(12):3669–78.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Petrucelli N, Daly MB, Feldman GL. BRCA1 and BRCA2 hereditary breast and ovarian cancer. In: Pagon RA, Adam MP, Ardinger HH, Wallace SE, Amemiya A, Bean LJH, et al., editors. GeneReviews(R). Seattle (WA)1993.

  10. Tilanus-Linthorst MM, Obdeijn IM, Hop WC, Causer PA, Leach MO, Warner E, et al. BRCA1 mutation and young age predict fast breast cancer growth in the Dutch, United Kingdom, and Canadian magnetic resonance imaging screening trials. Clin Cancer Res. 2007;13(24):7357–62.

    Article  CAS  PubMed  Google Scholar 

  11. Lakhani SR, Jacquemier J, Sloane JP, Gusterson BA, Anderson TJ, van de Vijver MJ, et al. Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations. J Natl Cancer Inst. 1998;90(15):1138–45.

    Article  CAS  PubMed  Google Scholar 

  12. Gilbert FJ, Warren RM, Kwan-Lim G, Thompson DJ, Eeles RA, Evans DG, et al. Cancers in BRCA1 and BRCA2 carriers and in women at high risk for breast cancer: MR imaging and mammographic features. Radiology. 2009;252(2):358–68.

    Article  PubMed  Google Scholar 

  13. Klijn JG. Early diagnosis of hereditary breast cancer by magnetic resonance imaging: what is realistic? J Clin Oncol. 2010;28(9):1441–5.

    Article  PubMed  Google Scholar 

  14. Warwick J, Birke H, Stone J, Warren RM, Pinney E, Brentnall AR, et al. Mammographic breast density refines Tyrer-Cuzick estimates of breast cancer risk in high-risk women: findings from the placebo arm of the International Breast Cancer Intervention Study I. Breast Cancer Res. 2014;16(5):451.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Sestak I, Cuzick J. Update on breast cancer risk prediction and prevention. Curr Opin Obstet Gynecol. 2015;27(1):92–7.

    Article  PubMed  Google Scholar 

  16. Hollingsworth AB, Stough RG. An alternative approach to selecting patients for high-risk screening with breast MRI. Breast J. 2014;20(2):192–7.

    Article  PubMed  Google Scholar 

  17. Kuhl CK, Schrading S, Leutner CC, Morakkabati-Spitz N, Wardelmann E, Fimmers R, et al. Mammography, breast ultrasound, and magnetic resonance imaging for surveillance of women at high familial risk for breast cancer. J Clin Oncol. 2005;23(33):8469–76.

    Article  PubMed  Google Scholar 

  18. Kriege M, Brekelmans CT, Boetes C, Besnard PE, Zonderland HM, Obdeijn IM, et al. Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition. N Engl J Med. 2004;351(5):427–37.

    Article  CAS  PubMed  Google Scholar 

  19. Leach MO, Boggis CR, Dixon AK, Easton DF, Eeles RA, Evans DG, et al. Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS). Lancet. 2005;365(9473):1769–78.

    Article  CAS  PubMed  Google Scholar 

  20. • Phi XA, Saadatmand S, De Bock GH, Warner E, Sardanelli F, Leach MO, et al. Contribution of mammography to MRI screening in BRCA mutation carriers by BRCA status and age: individual patient data meta-analysis. Br J Cancer. 2016;114(6):631–7. This source adds to the literature refining which imaging studies may be most effective for specific high risk groups.

    Article  CAS  PubMed  Google Scholar 

  21. Heijnsdijk EA, Warner E, Gilbert FJ, Tilanus-Linthorst MM, Evans G, Causer PA, et al. Differences in natural history between breast cancers in BRCA1 and BRCA2 mutation carriers and effects of MRI screening-MRISC, MARIBS, and Canadian studies combined. Cancer Epidemiol Biomarkers Prev. 2012;21(9):1458–68.

    Article  PubMed  Google Scholar 

  22. Mulder RL, Kremer LC, Hudson MM, Bhatia S, Landier W, Levitt G, et al. Recommendations for breast cancer surveillance for female survivors of childhood, adolescent, and young adult cancer given chest radiation: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group. Lancet Oncol. 2013;14(13):e621–9.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Ng AK, Garber JE, Diller LR, Birdwell RL, Feng Y, Neuberg DS, et al. Prospective study of the efficacy of breast magnetic resonance imaging and mammographic screening in survivors of Hodgkin lymphoma. J Clin Oncol. 2013;31(18):2282–8.

    Article  PubMed  Google Scholar 

  24. Tieu MT, Cigsar C, Ahmed S, Ng A, Diller L, Millar BA, et al. Breast cancer detection among young survivors of pediatric Hodgkin lymphoma with screening magnetic resonance imaging. Cancer. 2014;120(16):2507–13.

    Article  PubMed  Google Scholar 

  25. Freitas V, Scaranelo A, Menezes R, Kulkarni S, Hodgson D, Crystal P. Added cancer yield of breast magnetic resonance imaging screening in women with a prior history of chest radiation therapy. Cancer. 2013;119(3):495–503.

    Article  PubMed  Google Scholar 

  26. Zeng L, Lo G, Moshonov H, Liang J, Hodgson D, Crystal P. Breast background parenchymal enhancement on screening magnetic resonance imaging in women who received chest radiotherapy for childhood Hodgkin’s lymphoma. Acad Radiol. 2016;23(2):168–75.

    Article  PubMed  Google Scholar 

  27. Lee CH, Dershaw DD, Kopans D, Evans P, Monsees B, Monticciolo D, et al. Breast cancer screening with imaging: recommendations from the Society of Breast Imaging and the ACR on the use of mammography, breast MRI, breast ultrasound, and other technologies for the detection of clinically occult breast cancer. J Am Coll Radiol. 2010;7(1):18–27.

    Article  PubMed  Google Scholar 

  28. Brennan S, Liberman L, Dershaw DD, Morris E. Breast MRI screening of women with a personal history of breast cancer. AJR Am J Roentgenol. 2010;195(2):510–6.

    Article  PubMed  Google Scholar 

  29. • Gweon HM, Cho N, Han W, Yi A, Moon HG, Noh DY, et al. Breast MR imaging screening in women with a history of breast conservation therapy. Radiology. 2014;272(2):366–73. This article adds to the recent literature evaluating the use of screening breast MRI in women with a personal history of breast cancer.

    Article  PubMed  Google Scholar 

  30. Schacht DV, Yamaguchi K, Lai J, Kulkarni K, Sennett CA, Abe H. Importance of a personal history of breast cancer as a risk factor for the development of subsequent breast cancer: results from screening breast MRI. AJR Am J Roentgenol. 2014;202(2):289–92.

    Article  PubMed  Google Scholar 

  31. • Giess CS, Poole PS, Chikarmane SA, Sippo DA, Birdwell RL. Screening breast MRI in patients previously treated for breast cancer: diagnostic yield for cancer and abnormal interpretation rate. Acad Radiol. 2015;22(11):1331–7. This article adds to the recent literature evaluating the use of screening breast MRI in women with a personal history of breast cancer.

    Article  PubMed  Google Scholar 

  32. • Lehman CD, Lee JM, DeMartini WB, Hippe DS, Rendi MH, Kalish G, et al. Screening MRI in women with a personal history of breast cancer. J Natl Cancer Inst. 2016;108(3). This article adds to the recent literature evaluating the use of screening breast MRI in women with a personal history of breast cancer.

  33. • Destounis S, Arieno A, Morgan R. Personal history of premenopausal breast cancer as a risk factor for referral to screening breast MRI. Acad Radiol. 2016;23(3):353–7. This article adds to the recent literature evaluating the use of screening breast MRI in women with a personal history of breast cancer.

    Article  PubMed  Google Scholar 

  34. Friedlander LC, Roth SO, Gavenonis SC. Results of MR imaging screening for breast cancer in high-risk patients with lobular carcinoma in situ. Radiology. 2011;261(2):421–7.

    Article  PubMed  Google Scholar 

  35. Sung JS, Malak SF, Bajaj P, Alis R, Dershaw DD, Morris EA. Screening breast MR imaging in women with a history of lobular carcinoma in situ. Radiology. 2011;261(2):414–20.

    Article  PubMed  Google Scholar 

  36. King TA, Muhsen S, Patil S, Koslow S, Oskar S, Park A, et al. Is there a role for routine screening MRI in women with LCIS? Breast Cancer Res Treat. 2013;142(2):445–53.

    Article  PubMed  Google Scholar 

  37. Schwartz T, Cyr A, Margenthaler J. Screening breast magnetic resonance imaging in women with atypia or lobular carcinoma in situ. J Surg Res. 2015;193(2):519–22.

    Article  PubMed  Google Scholar 

  38. Boyd NF, Martin LJ, Yaffe MJ, Minkin S. Mammographic density and breast cancer risk: current understanding and future prospects. Breast Cancer Res. 2011;13(6):223.

    Article  PubMed  PubMed Central  Google Scholar 

  39. McCormack VA, dos Santos Silva I. Breast density and parenchymal patterns as markers of breast cancer risk: a meta-analysis. Cancer Epidemiol Biomarkers Prev. 2006;15(6):1159–69.

    Article  PubMed  Google Scholar 

  40. Othman E, Wang J, Sprague BL, Rounds T, Ji Y, Herschorn SD, et al. Comparison of false positive rates for screening breast magnetic resonance imaging (MRI) in high risk women performed on stacked versus alternating schedules. Springerplus. 2015;4:77.

    Article  PubMed  PubMed Central  Google Scholar 

  41. Mason C, Yokubaitis K, Howard E, Shah Z, Wang J. Impact of Henda’s law on the utilization of screening breast magnetic resonance imaging. Proc (Bayl Univ Med Cent). 2015;28(1):7–9.

    Google Scholar 

  42. Sardanelli F, Giuseppetti GM, Panizza P, Bazzocchi M, Fausto A, Simonetti G, et al. Sensitivity of MRI versus mammography for detecting foci of multifocal, multicentric breast cancer in fatty and dense breasts using the whole-breast pathologic examination as a gold standard. AJR Am J Roentgenol. 2004;183(4):1149–57.

    Article  PubMed  Google Scholar 

  43. Wright H, Listinsky J, Rim A, Chellman-Jeffers M, Patrick R, Rybicki L, et al. Magnetic resonance imaging as a diagnostic tool for breast cancer in premenopausal women. Am J Surg. 2005;190(4):572–5.

    Article  PubMed  Google Scholar 

  44. Berg WA, Zhang Z, Lehrer D, Jong RA, Pisano ED, Barr RG, et al. Detection of breast cancer with addition of annual screening ultrasound or a single screening MRI to mammography in women with elevated breast cancer risk. JAMA. 2012;307(13):1394–404.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  45. •• Emaus MJ, Bakker MF, Peeters PH, Loo CE, Mann RM, de Jong MD, et al. MR imaging as an additional screening modality for the detection of breast cancer in women aged 50–75 years with extremely dense breasts: the DENSE Trial Study Design. Radiology. 2015;277(2):527–37. This reference details a study to determine the additional value of MRI for breast cancer screening in women with dense breasts.

    Article  PubMed  Google Scholar 

  46. Schrading S, Kuhl C. MRI screening of women at average risk of breast cancer. J Clin Oncol 31, 2013 (suppl 26; abstr 21).

  47. Harvey SC, Di Carlo PA, Lee B, Obadina E, Sippo D, Mullen L. An abbreviated protocol for high-risk screening breast MRI saves time and resources. J Am Coll Radiol. 2016;13(4):374–80.

    Article  PubMed  Google Scholar 

  48. • Grimm LJ, Soo MS, Yoon S, Kim C, Ghate SV, Johnson KS. Abbreviated screening protocol for breast MRI: a feasibility study. Acad Radiol. 2015;22(9):1157–62. This reference details a study to determine the additional value of MRI for breast cancer screening in women with dense breasts.

    Article  PubMed  Google Scholar 

  49. Heacock L, Melsaether AN, Heller SL, Gao Y, Pysarenko KM, Babb JS, et al. Evaluation of a known breast cancer using an abbreviated breast MRI protocol: correlation of imaging characteristics and pathology with lesion detection and conspicuity. Eur J Radiol. 2016;85(4):815–23.

    Article  PubMed  Google Scholar 

  50. • Kuhl CK, Schrading S, Strobel K, Schild HH, Hilgers RD, Bieling HB. Abbreviated breast magnetic resonance imaging (MRI): first postcontrast subtracted images and maximum-intensity projection—a novel approach to breast cancer screening with MRI. J Clin Oncol. 2014;32(22):2304–10. This reference details a study to determine the additional value of MRI for breast cancer screening in women with dense breasts.

    Article  PubMed  Google Scholar 

  51. • Mango VL, Morris EA, David Dershaw D, Abramson A, Fry C, Moskowitz CS, et al. Abbreviated protocol for breast MRI: are multiple sequences needed for cancer detection? Eur J Radiol. 2015;84(1):65–70. This reference details a study to determine the additional value of MRI for breast cancer screening in women with dense breasts.

    Article  PubMed  Google Scholar 

  52. Kuhl C, Weigel S, Schrading S, Arand B, Bieling H, Konig R, et al. Prospective multicenter cohort study to refine management recommendations for women at elevated familial risk of breast cancer: the EVA trial. J Clin Oncol. 2010;28(9):1450–7.

    Article  PubMed  Google Scholar 

  53. Warner E, Hill K, Causer P, Plewes D, Jong R, Yaffe M, et al. Prospective study of breast cancer incidence in women with a BRCA1 or BRCA2 mutation under surveillance with and without magnetic resonance imaging. J Clin Oncol. 2011;29(13):1664–9.

    Article  PubMed  PubMed Central  Google Scholar 

  54. Evans DG, Kesavan N, Lim Y, Gadde S, Hurley E, Massat NJ, et al. MRI breast screening in high-risk women: cancer detection and survival analysis. Breast Cancer Res Treat. 2014;145(3):663–72.

    Article  PubMed  Google Scholar 

  55. Evans DG, Harkness EF, Howell A, Wilson M, Hurley E, Holmen MM, et al. Intensive breast screening in BRCA2 mutation carriers is associated with reduced breast cancer specific and all cause mortality. Hered Cancer Clin Pract. 2016;14:8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  56. Santoro F, Podo F, Sardanelli F. MRI screening of women with hereditary predisposition to breast cancer: diagnostic performance and survival analysis. Breast Cancer Res Treat. 2014;147(3):685–7.

    Article  PubMed  Google Scholar 

  57. Hodgson DC, Cotton C, Crystal P, Nathan PC. Impact of early breast cancer screening on mortality among young survivors of childhood Hodgkin’s lymphoma. J Natl Cancer Inst. 2016;108(7).

  58. Warner E. The role of magnetic resonance imaging in screening women at high risk of breast cancer. Top Magn Reson Imaging. 2008;19(3):163–9.

    Article  PubMed  Google Scholar 

  59. Le-Petross HT, Whitman GJ, Atchley DP, Yuan Y, Gutierrez-Barrera A, Hortobagyi GN, et al. Effectiveness of alternating mammography and magnetic resonance imaging for screening women with deleterious BRCA mutations at high risk of breast cancer. Cancer. 2011;117(17):3900–7.

    Article  PubMed  Google Scholar 

  60. Lowry KP, Lee JM, Kong CY, McMahon PM, Gilmore ME, Cott Chubiz JE, et al. Annual screening strategies in BRCA1 and BRCA2 gene mutation carriers: a comparative effectiveness analysis. Cancer. 2012;118(8):2021–30.

    Article  PubMed  Google Scholar 

  61. •• Phi XA, Houssami N, Obdeijn IM, Warner E, Sardanelli F, Leach MO, et al. Magnetic resonance imaging improves breast screening sensitivity in BRCA mutation carriers age >/= 50 years: evidence from an individual patient data meta-analysis. J Clin Oncol. 2015;33(4):349–56. This study demonstrates the higher sensitivity of MR and mammographic screening for detecting cancer compared to mammographic screening alone in women older than 50 years of age.

    Article  PubMed  Google Scholar 

  62. Griebsch I, Brown J, Boggis C, Dixon A, Dixon M, Easton D, et al. Cost-effectiveness of screening with contrast enhanced magnetic resonance imaging vs X-ray mammography of women at a high familial risk of breast cancer. Br J Cancer. 2006;95(7):801–10.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  63. Plevritis SK, Kurian AW, Sigal BM, Daniel BL, Ikeda DM, Stockdale FE, et al. Cost-effectiveness of screening BRCA1/2 mutation carriers with breast magnetic resonance imaging. JAMA. 2006;295(20):2374–84.

    Article  CAS  PubMed  Google Scholar 

  64. Saadatmand S, Tilanus-Linthorst MM, Rutgers EJ, Hoogerbrugge N, Oosterwijk JC, Tollenaar RA, et al. Cost-effectiveness of screening women with familial risk for breast cancer with magnetic resonance imaging. J Natl Cancer Inst. 2013;105(17):1314–21.

    Article  PubMed  Google Scholar 

  65. •• Niell BL, Gavenonis SC, Motazedi T, Chubiz JC, Halpern EP, Rafferty EA, et al. Auditing a breast MRI practice: performance measures for screening and diagnostic breast MRI. J Am Coll Radiol. 2014;11(9):883–9. This reference provides an analysis of key outcome measures for auditing a breast MRI screening program.

    Article  PubMed  PubMed Central  Google Scholar 

  66. Sickles EDOC. ACR BI-RADS® Follow-up and outcome monitoring. ACR BI-RADS® Atlas, Breast Imaging Reporting and Data System. Reston, VA: American College of Radiology; 2013.

  67. Haas JS, Hill DA, Wellman RD, Hubbard RA, Lee CI, Wernli KJ, et al. Disparities in the use of screening magnetic resonance imaging of the breast in community practice by race, ethnicity, and socioeconomic status. Cancer. 2016;122(4):611–7.

    Article  PubMed  Google Scholar 

  68. Onega T, Hubbard R, Hill D, Lee CI, Haas JS, Carlos HA, et al. Geographic access to breast imaging for US women. J Am Coll Radiol. 2014;11(9):874–82.

    Article  PubMed  PubMed Central  Google Scholar 

  69. Onega T, Lee CI, Benkeser D, Alford-Teaster J, Haas JS, Tosteson AN, et al. Travel burden to breast MRI and utilization: are risk and sociodemographics related? J Am Coll Radiol. 2016;13(6):611–9.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. New York University School of Medicine, 550 First Avenue, New York, NY, 10016, USA

    Samantha L. Heller & Linda Moy

Authors
  1. Samantha L. Heller
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Linda Moy
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Linda Moy.

Ethics declarations

Conflict of Interest

Samantha L. Heller and Linda Moy declare that they have no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

This article is part of the Topical Collection on Screening and Imaging

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Heller, S.L., Moy, L. Breast MRI Screening: Benefits and Limitations. Curr Breast Cancer Rep 8, 248–257 (2016). https://doi.org/10.1007/s12609-016-0230-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12609-016-0230-7

Keywords

Search

Navigation